A CASE OF LUNG ADENOCARCINOMA HARBORING BOTH A KRAS MUTATION AND AN EML4-ALK FUSION GENE WITH RESPONSE TO CRIZOTINIB

被引：0

作者：

Menefee, Michael E. ^{[1
]}

D'Amico, Thomas A. ^{[2
]}

机构：

[1] Mayo Clin, Rochester, MN USA

[2] Duke Univ, Med Ctr, Durham, NC 27706 USA

来源：

JOURNAL OF THORACIC ONCOLOGY | 2013年 / 8卷

关键词：

KRAS; Crizotinib; NSCLC; EML4-ALK;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P3.24-033

引用

页码：S1315 / S1316

页数：2

共 50 条

[41] Response to crizotinib in a non-small-cell lung cancer patient harboring an EML4-ALK fusion with an atypical LTBP1 insertion
Aguado, Cristina
Gil, Maria-de-los-Llanos
Yeste, Zaira
Gimenez-Capitan, Ana
Teixido, Cristina
Karachaliou, Niki
Viteri, Santiago
Rosell, Rafael
Molina-Vila, Miguel A.
ONCOTARGETS AND THERAPY, 2018, 11 : 1117 - 1120
[42] An extremely rare case of small-cell lung cancer harboring variant 2 of the EML4-ALK fusion gene
Toyokawa, Gouji
Takenoyama, Mitsuhiro
Taguchi, Kenichi
Toyozawa, Ryo
Inamasu, Eiko
Kojo, Miyako
Shiraishi, Yoshimasa
Morodomi, Yosuke
Takenaka, Tomoyoshi
Hirai, Fumihiko
Yamaguchi, Masafumi
Seto, Takashi
Shimokawa, Mototsugu
Ichinose, Yukito
LUNG CANCER, 2013, 81 (03) : 487 - 490
[43] Synergistic effects of crizotinib and radiotherapy in experimental EML4-ALK fusion positive lung cancer
Dai, Ying
Wei, Quanxiang
Schwager, Christian
Moustafa, Mahmoud
Zhou, Cheng
Lipson, Kenneth E.
Weichert, Wilko
Debus, Juergen
Abdollahi, Amir
RADIOTHERAPY AND ONCOLOGY, 2015, 114 (02) : 173 - 181
[44] A Case of Large-Cell Neuroendocrine Carcinoma Harboring an EML4-ALK Rearrangement with Resistance to the ALK Inhibitor Crizotinib
Omachi, Naoki
Shimizu, Shigeki
Kawaguchi, Tomoya
Tezuka, Kenji
Kanazu, Masaki
Tamiya, Akihiro
Asami, Kazuhiro
Okishio, Kyoichi
Kitaichi, Masanori
Atagi, Shinji
JOURNAL OF THORACIC ONCOLOGY, 2014, 9 (06) : E40 - E42
[45] Analysis of EML4-ALK fusion transcripts in plasma and platelets to monitor response to crizotinib in EML4-ALK positive non-small cell lung cancer patients (NSCLC)
Aguado, Cristina
Teixido, Cristina
Gimenez-Capitan, Ana
Gil, Maria de los Llanos
Rodriguez, Sonia
Viteri, Santiago
Karachaliou, Niki
Aldeguer, Erika
Peg, Vicente
Alonso, Lidia
Molina-Vila, Miguel Angel
Rosell, Rafael
CANCER RESEARCH, 2017, 77
[46] EML4-ALK fusion gene and efficacy of an ALK kinase inhibitor in lung cancer
Koivunen, Jussi P.
Mermel, Craig
Zejnullahu, Kreshnik
Murphy, Carly
Lifshits, Eugene
Holmes, Alison J.
Choi, Hwan Geun
Kim, Jhingook
Chiang, Derek
Thomas, Roman
Lee, Jinseon
Richards, William G.
Sugarbaker, David J.
Ducko, Christopher
Lindeman, Neal
Marcoux, J. Paul
Engelman, Jeffrey A.
Gray, Nathanael S.
Lee, Charles
Meyerson, Matthew
Janne, Pasi A.
CLINICAL CANCER RESEARCH, 2008, 14 (13) : 4275 - 4283
[47] Therapeutic strategies to overcome crizotinib resistance in non-small cell lung cancers harboring the fusion oncogene EML4-ALK
Katayama, Ryohei
Khan, Tahsin M.
Benes, Cyril
Lifshits, Eugene
Ebi, Hiromichi
Rivera, Victor M.
Shakespeare, William C.
Iafrate, A. John
Engelman, Jeffrey A.
Shaw, Alice T.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2011, 108 (18) : 7535 - 7540
[48] Concomitant novel ALK-SSH2, EML4-ALK and ARID2-ALK, EML4-ALK double-fusion variants and confer sensitivity to crizotinib in two lung adenocarcinoma patients, respectively
Hong Tao
Zhe Liu
Jing Mu
Fei Gai
Zhan Huang
Liang Shi
Diagnostic Pathology, 17
[49] Concomitant novel ALK-SSH2, EML4-ALK and ARID2-ALK, EML4-ALK double-fusion variants and confer sensitivity to crizotinib in two lung adenocarcinoma patients, respectively
Tao, Hong
Liu, Zhe
Mu, Jing
Gai, Fei
Huang, Zhan
Shi, Liang
DIAGNOSTIC PATHOLOGY, 2022, 17 (01)
[50] Prevalence of EML4-ALK Fusion Gene in Adenocarcinoma Lung Patients by Using Immuno Histo Chemistry
Talwar, V.
JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (09) : S167 - S167

← 1 2 3 4 5 →